BLOG / 🇺🇸 United States / insider ownership · · daily

US Activist Hedge Fund Institutional SEC 13D 13G — July 31, 2026

Activist & Institutional Activity

By Gunpowder Editorial ·

9 high priority 41 medium priority 50 total filings analysed

Executive Summary

The July 31, 2026 filings reveal a significant divergence in institutional and activist activity. Vanguard Capital Management made a broad, passive push across 25+ companies, crossing the 5% threshold in 16 names (e.g., Compass, Anavex, Conagra) while reducing or exiting positions in 8 others (e.g., Associated Banc-Corp, Chatham Lodging), signaling a portfolio rotation.

Activist activity is concentrated in Scully Royalty Ltd., where the Kellogg group (35.5% stake) and Neil Subin (13.0%) are engaged in a proxy fight and litigation over the 2025 AGM, creating a high-stakes control battle. Capital World Investors maintained its 34.9% stake in Diebold Nixdorf, while RA Capital executed a strategic exchange of shares for pre-funded warrants at Inhibikase Therapeutics to cap ownership at 9.99%. Insider selling is notable at Sanara MedTech (complete exit by Tall Pines Capital) and Diana Shipping (stake fell below 5%). The overall theme is one of passive rebalancing by Vanguard, mixed with targeted activist pressure and strategic positioning by specialized funds.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Schedule 13D · Schedule 13G

Tracking the trend? Catch up on the prior US Activist Hedge Fund Institutional SEC 13D 13G digest from July 24, 2026.

Investment Signals (11)

  • Scully Royalty Ltd. (SRL) ↓ (BULLISH)
    ▲

    Kellogg group (35.5% stake) and Neil Subin (13.0%) are aligned in a proxy fight to replace management, with litigation ongoing over the 2025 AGM. The Cayman court ruled directors lacked authority to postpone the AGM, but also blocked Subin's nominees, creating a volatile situation. This is a high-conviction activist play with potential for board change and value unlock.

  • Inhibikase Therapeutics (IKT) (BULLISH)
    ▲

    RA Capital exchanged 18M shares for pre-funded warrants with a 9.99% beneficial ownership blocker, indicating a strategic move to maintain influence while limiting downside. The blocker prevents dilution above 9.99%, suggesting RA Capital sees significant upside but wants to avoid triggering a change-of-control provision.

  • Diebold Nixdorf (DBD) (BULLISH)
    ▲

    Capital World Investors maintained its 34.9% stake, unchanged from the prior filing. This stability signals strong long-term conviction from a top-tier institutional investor, providing a floor for the stock.

  • Sanara MedTech (SMTI) (BEARISH)
    ▲

    Tall Pines Capital and Stonebridge Wealth Management (both controlled by Christopher Plahm) completely exited their position, reducing ownership from above 5% to 0%. This is a strong bearish signal from a previously significant insider.

  • Diana Shipping (DSX) (BEARISH)
    ▲

    F. Laeisz GmbH and Nikolaus Schues reduced their stake below 5% (now 4.9%), triggering an exit filing. This follows a change in investment intent from activist to passive, suggesting waning confidence in the shipping sector.

  • NN Inc. (NNBR) ↓ (BULLISH)
    ▲

    Legion Partners Asset Management disclosed a 6.5% activist stake and accelerated vesting of 49,079 restricted shares from a director. This signals active engagement and potential for operational or strategic changes.

  • Vanguard's Broad Passive Push (BULLISH)
    ▲

    Vanguard crossed the 5% threshold in 16 companies (e.g., Compass, Anavex, Conagra, EZCORP, IDEAYA, Eledon, Chart Industries, Comtech, Arbor Realty, Brookdale, CIBC, Cohu, Avanos, Centrus, Brady) indicating a systematic allocation increase, likely via index fund inflows. This provides a passive support floor for these stocks.

  • Vanguard's Exits/Reductions (BEARISH)
    ▲

    Vanguard reduced stakes below 5% in 8 companies (Associated Banc-Corp, Chatham Lodging, GCM Grosvenor, Citizens Community Bancorp, Colony Bankcorp, BlueLinx, Bar Harbor Bankshares, Bassett Furniture), signaling a rotation out of smaller financials and REITs. This could pressure these stocks.

  • Bexil Investment Trust (BXIL) ↓ (BULLISH)
    ▲

    Winmill & Co. purchased 45,317 shares at $16.78-$17.20 in the 60 days prior to the filing, increasing the Winmill family's stake to 15.3%. This insider buying at a specific price range provides a valuation floor.

  • Mercer International (MERC) (BULLISH)
    ▲

    Peter Kellogg purchased 419,743 shares at $0.90-$0.91 on June 1, 2026, increasing his stake to 40.25%. This insider buying at a low price signals deep value conviction.

  • Apollo S3 Private Markets Fund ↓ (NEUTRAL)
    ▲

    Ongoing Adviser Transfer Transactions (no consideration) between Holdings and ASPM S3 AIV suggest internal restructuring, not a market signal. Neutral impact.

Risk Flags (8)

  • Scully Royalty Ltd. / Litigation Risk↓ [HIGH RISK]
    ▼

    The Cayman Islands court ruling created a stalemate—no new directors were elected, and incumbents remain. The company has also filed a complaint against IAT Reinsurance Co. in U.S. District Court. This legal overhang could delay any value-unlocking event and increase costs.

  • Sanara MedTech / Insider Exit Risk↓ [HIGH RISK]
    ▼

    Complete exit by Tall Pines Capital and Stonebridge Wealth Management (both controlled by Christopher Plahm) is a red flag. The filing shows 0% ownership, suggesting a loss of confidence or a forced liquidation.

  • Diana Shipping / Sector Risk↓ [MEDIUM RISK]
    ▼

    The exit filing by F. Laeisz GmbH (stake fell below 5%) follows a change from activist to passive intent, indicating a lack of conviction in the dry bulk shipping sector. This could precede further selling.

  • Vanguard's Rotation Out of Small Financials [MEDIUM RISK]
    ▼

    Vanguard reduced stakes below 5% in Associated Banc-Corp (4.77%), Chatham Lodging (4.91%), Citizens Community Bancorp (4.94%), Colony Bankcorp (4.92%), BlueLinx (4.94%), Bar Harbor Bankshares (4.96%), and Bassett Furniture (4.79%). This systematic reduction could signal a sector-wide headwind for small-cap financials and REITs.

  • Inhibikase Therapeutics / Dilution Risk↓ [MEDIUM RISK]
    ▼

    RA Capital's exchange of 18M shares for pre-funded warrants with a 9.99% blocker means the company has a large overhang of potential dilution (18M shares) if the blocker is removed or if the stock appreciates significantly.

  • NN Inc. / Activist Overhang↓ [MEDIUM RISK]
    ▼

    Legion Partners' 6.5% stake and the accelerated vesting of restricted shares could lead to a proxy fight or forced strategic changes, creating near-term uncertainty.

  • Bexil Investment Trust / Low Liquidity Risk↓ [LOW RISK]
    ▼

    The Winmill family controls 15.3% of a small investment trust. Recent purchases at $16.78-$17.20 suggest a narrow price range, but low liquidity could amplify volatility.

  • Pharvaris N.V. / Dilution Risk↓ [LOW RISK]
    ▼

    LSP V's stake dropped from above 5% to 4.9% due to a May 2026 underwritten offering. This dilution event could pressure the stock if the offering was at a discount.

Opportunities (9)

  • Scully Royalty Ltd. / Activist Catalyst↓ (OPPORTUNITY)
    ◆

    With the Kellogg group (35.5%) and Neil Subin (13.0%) aligned, they control 48.5% of the vote. The ongoing litigation creates a binary catalyst—if they win the right to elect directors, a board shakeup could unlock significant value.

  • Mercer International / Deep Value Play↓ (OPPORTUNITY)
    ◆

    Peter Kellogg purchased 419,743 shares at $0.90-$0.91, and his total stake is 40.25%. The stock trades at a fraction of book value, and insider buying at these levels signals a potential turnaround or asset sale.

  • Inhibikase Therapeutics / Strategic Positioning↓ (OPPORTUNITY)
    ◆

    RA Capital's use of pre-funded warrants with a 9.99% blocker is a sophisticated structure that allows them to maintain a large economic interest while limiting voting power. This suggests they expect significant upside and want to avoid triggering a change-of-control clause.

  • Diebold Nixdorf / Institutional Stability↓ (OPPORTUNITY)
    ◆

    Capital World Investors' 34.9% stake, unchanged for months, provides a strong institutional anchor. The company may be a candidate for a take-private or strategic sale, given the concentrated ownership.

  • NN Inc. / Activist Engagement↓ (OPPORTUNITY)
    ◆

    Legion Partners' 6.5% stake and the accelerated vesting of director shares suggest they are pushing for change. NN Inc. is a small-cap industrial with potential for operational improvements under activist pressure.

  • Bexil Investment Trust / Insider Buying Signal↓ (OPPORTUNITY)
    ◆

    Winmill & Co. purchased 45,317 shares at $16.78-$17.20, a clear insider buying signal. The trust's net asset value (NAV) may be above the current price, creating a potential discount-to-NAV play.

  • Vanguard's New 5%+ Stakes / Passive Support (OPPORTUNITY)
    ◆

    Vanguard crossed the 5% threshold in 16 companies, including Compass (5.02%), Anavex (5.03%), Conagra (5.28%), EZCORP (5.02%), IDEAYA (5.08%), Eledon (5.05%), Chart Industries (5.15%), Comtech (5.01%), Arbor Realty (5.08%), Brookdale (5.0%), CIBC (5.01%), Cohu (5.01%), Avanos (5.0%), Centrus (5.02%), and Brady (5.01%). This passive buying provides a technical floor and reduces downside risk.

  • Centrus Energy / Nuclear Fuel Play↓ (OPPORTUNITY)
    ◆

    Vanguard's 5.02% stake in Centrus Energy (LEU) comes at a time of increased focus on nuclear fuel supply chains. The stock is a pure-play on U.S. uranium enrichment, and Vanguard's passive support adds credibility.

  • Establishment Labs Holdings / Activist Potential↓ (OPPORTUNITY)
    ◆

    JW Asset Management disclosed a 9.15% passive stake. While currently passive, a 9.15% stake is large enough to become activist if performance falters. The company is a medical aesthetics play with high growth potential.

Sector Themes (6)

  • Passive Institutional Rebalancing by Vanguard
    ◆

    Vanguard filed 25+ Schedule 13G amendments, crossing the 5% threshold in 16 companies and reducing below 5% in 8. This is a systematic portfolio rebalancing, likely driven by index fund flows. The new 5%+ positions span diverse sectors (tech, healthcare, financials, energy), while reductions are concentrated in small-cap financials and REITs. Implication: Vanguard's moves provide a passive support floor for the 16 new positions but create selling pressure for the 8 reduced ones.

  • Concentrated Activist Activity in Scully Royalty Ltd.
    ◆

    Two separate activist groups (Kellogg at 35.5% and Subin at 13.0%) are targeting the same company, creating a rare dual-activist situation. The combined 48.5% stake gives them significant leverage. The litigation over the 2025 AGM is a key catalyst. Implication: This is a high-conviction activist play with a binary outcome—either a board shakeup or a prolonged legal battle.

  • Strategic Use of Pre-Funded Warrants in Biotech
    ◆

    RA Capital's exchange of shares for pre-funded warrants at Inhibikase Therapeutics is a sophisticated strategy to cap ownership at 9.99% while maintaining economic exposure. This structure is becoming more common in biotech to avoid triggering change-of-control provisions. Implication: Investors should watch for similar structures in other biotech filings as a signal of strategic positioning.

  • Insider Buying at Deep Value Levels
    ◆

    Peter Kellogg's purchase of Mercer International shares at $0.90-$0.91 and Winmill & Co.'s purchases of Bexil Investment Trust at $16.78-$17.20 are examples of insider buying at what appear to be distressed or deep value levels. Implication: These purchases provide a valuation floor and signal management's belief that the stock is undervalued.

  • Insider Exits and Stake Reductions
    ◆

    The complete exit by Tall Pines Capital from Sanara MedTech and the reduction below 5% by F. Laeisz GmbH in Diana Shipping are bearish signals. These exits may reflect sector-specific headwinds (medtech and shipping) or company-specific issues. Implication: Investors should scrutinize these sectors for broader weakness.

  • Stable Institutional Holdings in Industrials
    ◆

    Capital World Investors' unchanged 34.9% stake in Diebold Nixdorf and the Kellogg group's 40.25% stake in Mercer International show strong institutional conviction in select industrial names. Implication: These stocks may be less volatile and could be candidates for take-private or strategic transactions.

Watch List (8)

  • Scully Royalty Ltd. / Litigation Outcome↓
    👁

    The Cayman Islands court ruling and the U.S. District Court complaint are key catalysts. Watch for appeals or a settlement that could allow the Kellogg/Subin group to elect directors. Next court date unknown—monitor filings.

  • NN Inc. / Activist Actions↓
    👁

    Legion Partners' 6.5% stake and the accelerated vesting of director shares suggest they may push for board representation or a strategic review. Watch for a 13D amendment or a proxy statement.

  • Inhibikase Therapeutics / RA Capital's Next Move↓
    👁

    RA Capital's pre-funded warrant structure allows them to increase their stake without triggering the 9.99% blocker. Watch for any exercise of warrants or additional purchases.

  • Vanguard's 5%+ Positions / Earnings Season
    👁

    Vanguard crossed the 5% threshold in 16 companies. Watch their upcoming earnings calls for any commentary on Vanguard's influence or engagement.

  • Sanara MedTech / Insider Selling Follow-Up↓
    👁

    The complete exit by Tall Pines Capital is a red flag. Watch for any additional insider selling or a material adverse event disclosure.

  • Diana Shipping / Further Stake Reductions↓
    👁

    The exit filing by F. Laeisz GmbH could be followed by other large holders. Watch for additional 13G/A filings or a decline in the stock price.

  • Mercer International / Peter Kellogg's Next Move↓
    👁

    Kellogg purchased shares at $0.90-$0.91 and now holds 40.25%. Watch for any tender offer, going-private proposal, or further open-market purchases.

  • Bexil Investment Trust / NAV Discount↓
    👁

    The Winmill family's purchases at $16.78-$17.20 suggest the stock may trade at a discount to NAV. Watch for any catalyst that could close the discount, such as a tender offer or liquidation.

Filing Analyses (50)
DIEBOLD NIXDORF, Inc SC 13D/A neutral materiality 6/10

31-07-2026

Capital World Investors (CWI) filed Amendment No. 4 to its Schedule 13D with the SEC on July 31, 2026, reporting beneficial ownership of 11,844,145 common shares of Diebold Nixdorf, Inc., representing 34.9% of the outstanding shares. The filing reflects a change in percentage due to a change in the issuer's outstanding share count, not a change in CWI's shareholding. CWI's stake remains substantial at over one-third of the company.

  • · This Amendment No. 4 amends the Schedule 13D originally filed on August 21, 2023, and previously amended on October 24, 2023, March 11, 2024, and February 17, 2026.
  • · The filing was made solely to reflect a change in percentage of beneficial ownership due to a change in the issuer's outstanding common shares, not due to any transaction by CWI.
  • · CWI's aggregate shareholding of 11,844,145 shares remained unchanged from the prior filing.
BEXIL INVESTMENT TRUST SC 13D/A neutral materiality 6/10

31-07-2026

Bexil Securities LLC and related Winmill family entities filed an amended Schedule 13D with the SEC on July 31, 2026, disclosing aggregate beneficial ownership of approximately 15.3% of Bexil Investment Trust's shares of beneficial interest. The filing details recent open-market purchases by Winmill & Co. Incorporated totaling over 40,000 shares between June 23 and July 29, 2026, at prices ranging from $16.78 to $17.20 per share. The reporting group includes multiple affiliated entities and individuals, with Thomas B. Winmill being the largest individual holder at 15.3%.

  • · The filing is an amendment to Schedule 13D, indicating a change in beneficial ownership.
  • · Winmill & Co. Incorporated purchased a total of 45,317 shares in the 60 days prior to the filing.
  • · The price range for recent purchases was $16.78 to $17.20 per share.
  • · Bexil Advisers LLC serves as the investment manager of the Issuer under an agreement dated September 19, 2012, receiving an annual fee of 0.95% of managed assets.
  • · The Issuer has an executive committee comprised solely of Thomas B. Winmill.
  • · The audit, nominating, and governance committees are comprised of independent directors Roger A. Atkinson, Jon Tomasson, and Peter K. Werner.
  • · Midas Securities Group, Inc. owns approximately 21% of the outstanding shares of Bexil Corporation.
  • · The Winmill Family Trust owns all of the voting stock of Winmill & Co. Incorporated.
  • · The Trust has four trustees (Mark C. Winmill, Thomas B. Winmill, William M. Winmill, Woodworth B. Winmill) with equal voting rights, requiring majority agreement for voting and investment decisions.
  • · Several reporting persons disclaim beneficial ownership of shares held by others in the group.
Apollo S3 Private Markets Fund SC 13D/A neutral materiality 5/10

31-07-2026

This Schedule 13D/A filing by APO Corp. and related entities discloses beneficial ownership of 29.9% of Apollo S3 Private Markets Fund's Class I shares, representing 3,173,359.34 shares. The filing details ongoing Adviser Transfer Transactions, where Holdings disposed of shares and ASPM S3 AIV acquired shares on four dates between October 2025 and July 2026, with no consideration exchanged. The reporting persons disclaim beneficial ownership and group status.

  • · Holdings disposed of 23,543, 23,601.925, 23,622.078, and 23,657.383 Class I shares on October 29, 2025, January 29, 2026, April 29, 2026, and July 29, 2026, respectively, as part of Adviser Transfer Transactions.
  • · ASPM S3 AIV acquired 5,050, 5,062.528, 5,082.814, and 5,095.521 Class I shares on the same respective dates.
  • · The Adviser Transfer Transactions involve transfers for no consideration to eligible investors who contributed capital on or before June 30, 2025, up to 3% of such investors' shares.
  • · No transactions in Class I shares were effected by the reporting persons in the past 60 days, except as disclosed.
Inhibikase Therapeutics, Inc. SC 13G/A neutral materiality 6/10

31-07-2026

RA Capital Management, L.P. and affiliated entities filed an amended Schedule 13G disclosing beneficial ownership of 14,653,994 shares of Inhibikase Therapeutics, Inc. (IKT), representing 9.99% of the outstanding common stock. The filing reflects a July 29, 2026 transaction in which the Fund exchanged 18,030,000 shares of common stock for pre-funded warrants with a beneficial ownership blocker that caps ownership at 9.99%. The filing is passive in nature, with the Reporting Persons certifying the securities were not acquired to change or influence control of the issuer.

  • · The Fund directly holds 6,970,000 shares of common stock and pre-funded warrants exercisable for up to 18,030,000 shares.
  • · The pre-funded warrants contain a Beneficial Ownership Blocker preventing exercise that would result in beneficial ownership exceeding 9.99% of common stock outstanding.
  • · The Fund is currently prohibited from exercising the pre-funded warrants to the extent such exercise would result in beneficial ownership of more than 7,683,994 shares.
  • · The beneficial ownership percentage is based on 132,032,636 shares outstanding as of May 1, 2026, plus 25,000,000 shares issued to the Fund on July 10, 2026, less 18,030,000 shares surrendered in exchange for pre-funded warrants on July 29, 2026.
  • · RA Capital serves as investment adviser for the Fund and has been delegated sole voting and dispositive power over the Fund's portfolio securities.
  • · The Fund has divested voting and investment power over the reported securities and may not revoke that delegation on less than 61 days' notice.
  • · The Reporting Persons expressly disclaim status as a 'group' for purposes of this Schedule 13G/A.
C3is Inc. SC 13G neutral materiality 5/10

31-07-2026

Lind Global Fund III LP, along with its general partner Lind Global Partners III LLC and managing member Jeff Easton, filed a Schedule 13G with the SEC on July 31, 2026, disclosing beneficial ownership of 1,325,482 shares of C3is Inc. (CISS), representing 9.99% of the company's common stock. The ownership consists of 1,140,000 units, each comprising one common share and one warrant, with the beneficial ownership limited by a conversion restriction that prevents the holder from exceeding 9.99% ownership. The filing indicates a passive investment intent, as the securities were not acquired to change or influence control of the issuer.

  • · The filing is made under Rule 13d-1(c), indicating a passive investor status.
  • · The warrants include a conversion limitation preventing beneficial ownership exceeding 9.99% of the company.
  • · The reporting persons' business address is 444 Madison Ave, Floor 41, New York, NY 10022.
  • · The issuer's principal business office is at 331 Kifissias Avenue, Kifissia, Athens, Greece, 14561.
REVIVA PHARMACEUTICALS HOLDINGS, INC. SC 13G/A neutral materiality 2/10

31-07-2026

UBS Group AG filed a Schedule 13G/A with the SEC on July 31, 2026, disclosing a 0.0% beneficial ownership stake in REVIVA PHARMACEUTICALS HOLDINGS, INC. as of June 30, 2026. The filing indicates UBS and its subsidiaries hold no shares of RVPH common stock, reflecting a complete exit from any previous position.

NN INC SC 13D/A neutral materiality 6/10

31-07-2026

Legion Partners Asset Management and related entities filed an amended Schedule 13D disclosing aggregate beneficial ownership of approximately 6.5% of NN Inc. common stock as of July 29, 2026. The filing details the purchase prices for shares held by various Legion funds and reports a letter agreement with the issuer that accelerated vesting of 49,079 restricted shares awarded to director Raymond T. White, with all economic benefits of those shares transferred to Legion Partners Asset Management. The filing also notes the termination of the issuer's obligations under Section 1 of the Cooperation Agreement.

  • · The filing is an amendment to Schedule 13D (SC 13D/A) filed on July 31, 2026.
  • · The aggregate purchase price for shares owned directly by Legion Partners I is approximately $32,766,696.
  • · The aggregate purchase price for shares owned directly by Legion Partners II is approximately $934,088.
  • · The aggregate purchase price for shares owned directly by Legion Partners XI is approximately $7,483,246.
  • · The aggregate purchase price for shares owned directly by Legion Partners Holdings is approximately $2,568.
  • · The letter agreement accelerated vesting of 49,079 restricted shares awarded to Raymond T. White on March 18, 2026.
  • · The Reporting Persons waived replacement rights under Section 1(f) of the Cooperation Agreement and acknowledged termination of the issuer's obligations under Section 1 of that agreement.
Churchill Capital Corp XI SC 13G/A neutral materiality 3/10

31-07-2026

Millennium Management LLC and related entities disclosed a 3.6% beneficial ownership stake in Churchill Capital Corp XI (CCXI), holding 1,490,636 Class A Ordinary Shares as of June 30, 2026. The filing is an amendment to Schedule 13G, indicating the stake is held for investment purposes and not to influence control. No prior period comparison is available in this filing.

  • · The filing is an amendment to Schedule 13G (SC 13G/A), filed under Rule 13d-1(c).
  • · The securities are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Israel A. Englander.
  • · The filing includes a Joint Filing Agreement dated July 30, 2026, among Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander.
ESTABLISHMENT LABS HOLDINGS INC. SC 13G neutral materiality 6/10

31-07-2026

JW Asset Management, LLC and related entities disclosed a 9.15% beneficial ownership stake in Establishment Labs Holdings Inc. as of June 30, 2026, holding 2,692,856 common shares. The filing indicates that JW Asset Management acts as an investment adviser, with Jason G. Wild being the ultimate controlling person. No period-over-period comparison is available as this is an initial filing.

  • · The filing is a Schedule 13G, indicating passive investment intent (not activist).
  • · JW Asset Management, LLC is a Delaware limited liability company acting as an investment adviser.
  • · Jason G. Wild is the ultimate controlling person of all reported shares.
  • · The filing date is July 31, 2026, with ownership measured as of June 30, 2026.
Baird Medical Investment Holdings Ltd SC 13D neutral materiality 6/10

31-07-2026

A Schedule 13D filing reveals that ExcelFin SPAC LLC, Grand Fortune Capital (HK) Co Ltd, and Grand Fortune Capital LLC collectively beneficially own 11,543,047 ordinary shares of Baird Medical Investment Holdings Ltd (BDMD), representing approximately 31.5% of the outstanding shares. The largest holder is Grand Fortune Capital (HK) Co Ltd with 19.1%, followed by ExcelFin SPAC LLC with 11.6%, and Grand Fortune Capital LLC with 0.8% on an as-converted basis. The filing indicates no recent transactions in the past 60 days and no present plans for major corporate actions, but the reporting persons may acquire or dispose of shares depending on market conditions.

  • · The filing is a joint Schedule 13D by three entities: ExcelFin SPAC LLC, Grand Fortune Capital (HK) Co Ltd, and Grand Fortune Capital LLC.
  • · ExcelFin SPAC LLC's 4,249,031 shares include 2,620,625 founder/sponsor shares from the business combination and 278,406 shares converted from working capital loans at $10.20 per share.
  • · Grand Fortune Capital (HK) Co Ltd's 7,004,016 shares include 2,464,985 shares acquired in the business combination (of which 564,437 are subject to an earnout) and shares held by ExcelFin and GFC.
  • · Grand Fortune Capital LLC holds 290,000 Series A Preferred Shares convertible into ordinary shares at any time.
  • · No transactions in the issuer's securities were effected by the reporting persons during the past 60 days.
  • · The reporting persons disclaim beneficial ownership except for their pecuniary interest.
  • · The filing includes a joint filing agreement dated May 5, 2026.
DIANA SHIPPING INC. SC 13G neutral materiality 3/10

31-07-2026

F. Laeisz GmbH, KG Reederei N. Schues mbH + Co., and Nikolaus H. Schues (the Reporting Persons) filed an exit Schedule 13G on July 31, 2026, disclosing they have ceased to be beneficial owners of more than 5% of Diana Shipping Inc. common shares. As of the filing, each Reporting Person beneficially owns 6,073,296 shares, representing 4.9% of the 124,402,479 shares outstanding, down from a prior stake above 5%.

  • · The Reporting Persons initially filed a Schedule 13G on October 18, 2024, amended it on April 30, 2025, and later filed a Schedule 13D on June 12, 2025 after a change in investment intent on June 6, 2026.
  • · As of April 17, 2026, the Reporting Persons no longer held the shares with a purpose of changing or influencing control, leading to a reversion to Schedule 13G on April 21, 2026.
  • · This Amendment No. 1 is an exit filing because the Reporting Persons' ownership fell below 5%.
  • · F. Laeisz GmbH is 48% owned and controlled by KG Reederei; KG Reederei is 68.75% owned and controlled by Nikolaus H. Schues.
ONE STOP SYSTEMS, INC. SC 13G/A neutral materiality 5/10

31-07-2026

Vladimir Galkin, Angelica Galkin, and the Angelica Galkin Revocable Trust filed a Schedule 13G/A disclosing aggregate beneficial ownership of 1,500,000 shares of One Stop Systems, Inc. (OSS) common stock, representing 6.1% of the 24,769,017 shares outstanding as of March 31, 2026. The filing reflects a passive investment intent and updates the prior Schedule 13G. No period-over-period comparison is available as the prior filing was not provided.

  • · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(c), indicating passive investment intent.
  • · Vladimir Galkin and Angelica Galkin are U.S. citizens; the trust is organized in Florida.
  • · The reporting persons may be deemed a group under Section 13(d)(3) of the Exchange Act.
Voyager Therapeutics, Inc. SC 13G/A neutral materiality 6/10

31-07-2026

Integrated Core Strategies (US) LLC, an affiliate of Millennium Management, filed a Schedule 13G/A disclosing beneficial ownership of 4,437,293 shares of Voyager Therapeutics, Inc. common stock, representing 7.3% of shares outstanding as of June 30, 2026. The filing also reports that Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander may be deemed to beneficially own 4,442,951 shares (7.4%) through entities under their control. The filing is made under Rule 13d-1(c) and certifies that the securities were not acquired with the purpose of changing or influencing control of the issuer.

  • · The filing is an amendment (Schedule 13G/A) filed on July 31, 2026, with a date of change of July 31, 2026.
  • · The securities are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC and Israel A. Englander.
  • · The filing includes a Joint Filing Agreement dated July 30, 2026, among the reporting persons.
  • · The filing is made under Rule 13d-1(c), indicating the filer is a passive investor not seeking to influence control.
StepStone Group Inc. SC 13G/A neutral materiality 5/10

31-07-2026

Millennium Management LLC and affiliated entities disclosed a 6.8% beneficial ownership stake in StepStone Group Inc. (STEP) as of June 30, 2026, holding 5,619,498 Class A shares. The filing is an amendment to Schedule 13G under Rule 13d-1(c), indicating passive investment intent. The stake is held across multiple entities, with Integrated Core Strategies (US) LLC holding 4,967,835 shares (6.0%).

  • · Filing date: July 31, 2026; as of date: June 30, 2026
  • · Filing is an amendment to Schedule 13G under Rule 13d-1(c), indicating passive investment
  • · Joint filing agreement dated July 30, 2026 among the reporting entities
  • · Israel A. Englander is the sole voting trustee of the managing member of Millennium Group Management LLC
  • · The reporting entities disclaim beneficial ownership of securities held by other entities
Scully Royalty Ltd. SC 13D/A negative materiality 8/10

31-07-2026

Neil S. Subin and related entities (the 'Reporting Persons') filed Amendment No. 7 to Schedule 13D with the SEC on July 31, 2026, disclosing aggregate beneficial ownership of 1,985,952 common shares of Scully Royalty Ltd., representing 13.0% of the 15,226,351 shares outstanding as of November 24, 2025. The amendment updates ownership details, adds MFTC, LLC as a new reporting person (trustee of two trusts holding 353,469 shares, 2.3%), and describes ongoing litigation with the company's directors over the validity of the 2025 annual general meeting and director nominations. The Cayman Islands court ruled that directors lacked authority to postpone the AGM but also that only directors could appoint a chairman, resulting in no new directors being elected and the incumbent directors remaining in office.

  • · The Cayman Islands Grand Court ruled that company directors did not have authority to postpone the 2025 AGM, but also that only directors could appoint a chairman, preventing MILFAM proxyholders from transacting business.
  • · As a result of the court ruling, no new directors were elected and the incumbent directors remain in office.
  • · MILFAM is entitled to appeal the court's decision regarding the election of its nominees.
  • · MFTC, LLC was appointed trustee of Susan F. Miller Spousal Trust A-4 and Miller Family Education and Medical Trust effective April 4, 2026, replacing Neil S. Subin as trustee.
  • · The Kellogg Parties (Peter R. Kellogg, Goose Creek Capital, Inc., Charles K. Kellogg, IAT Reinsurance Company Ltd., IAT Insurance Group, Inc., Harco National Insurance Company) filed a separate Schedule 13D on the same date.
NAM TAI PROPERTY INC. SC 13D/A neutral materiality 5/10

31-07-2026

This Amendment No. 5 to Schedule 13D reports that Peter Kellogg transferred voting control of Goose Creek Capital, Inc. to Charles Kellogg via a stock purchase agreement (closed January 19, 2021), and adds IAT Reinsurance Company Ltd., IAT Insurance Group, Inc., and Harco National Insurance Company as Reporting Persons. The Reporting Persons collectively beneficially own 12,993,460 shares (21.46%) of Nam Tai Property Inc. However, an oral agreement among the Kellogg family gives Peter Kellogg exclusive voting and dispositive power over all shares held by family members and entities, meaning Charles Kellogg disclaims beneficial ownership despite holding the voting equity of Goose Creek Capital.

  • · The transfer of 100,005 Class A Voting Preferred Shares of Goose Creek Capital, Inc. from Peter Kellogg to Charles Kellogg closed on January 19, 2021.
  • · No transactions in the Shares were effected by any Reporting Person during the past 60 days.
  • · An oral agreement among Peter Kellogg and his family members gives Peter Kellogg exclusive voting and dispositive power over all shares held by family members and entities.
  • · Charles Kellogg expressly disclaims beneficial ownership of the Shares except to the extent of his pecuniary interest.
  • · The Reporting Persons have entered into a Joint Filing Agreement (Exhibit 99.1).
Scully Royalty Ltd. SC 13D/A neutral materiality 8/10

31-07-2026

Peter R. Kellogg and related entities filed an amended Schedule 13D disclosing a combined 35.5% beneficial ownership in Scully Royalty Ltd. (SRL). The filing reveals a transfer of voting control of Goose Creek Capital from Peter to Charles Kellogg, and the addition of several insurance subsidiaries as reporting persons. The reporting group is aligned with MILFAM to nominate directors and potentially replace current management, following litigation over the 2025 AGM. No financial results or period-over-period comparisons are included in this filing.

  • · The transfer of Goose Creek Capital voting control from Peter to Charles Kellogg closed on January 19, 2021, but is only now being fully reflected in this amendment.
  • · The reporting group holds a combined 35.5% stake (Peter Kellogg) and 23.6% (Charles Kellogg), with overlapping ownership through subsidiaries.
  • · On July 15, 2026, Scully Royalty Ltd. filed a complaint in U.S. District Court for the Southern District of Florida against IAT Reinsurance Co. (details not provided in this filing).
  • · The 2025 AGM resulted in no directors being elected; current directors remain in office pending further legal action or a new meeting.
MERCER INTERNATIONAL INC. SC 13D/A neutral materiality 6/10

31-07-2026

Peter Kellogg and related entities collectively beneficially own 26,950,672 shares (40.25%) of Mercer International Inc., with Charles Kellogg deemed to beneficially own 20,220,000 shares (30.20%). Peter Kellogg purchased 419,743 shares in open market transactions on June 1, 2026, at prices between $0.8984 and $0.91 per share. The filing reflects a 2019 transfer of Class A Voting Preferred Stock of Goose Creek Capital from Peter to Charles Kellogg, and adds several intermediate holding companies and insurance subsidiaries as Reporting Persons.

  • · Peter Kellogg has the exclusive right to make all voting and disposition decisions for shares held by family entities under an oral agreement.
  • · Charles Kellogg acquired 100,005 shares of Class A Voting Preferred Stock of Goose Creek Capital via a Stock Purchase Agreement dated December 2, 2019, which closed on January 19, 2021.
  • · The filing adds IAT Reinsurance Company Ltd., IAT Insurance Group, Inc., and Harco National Insurance Company as Reporting Persons, though their shares were previously included in aggregate ownership figures.
  • · Peter Kellogg's sole voting/dispositive power covers 8,730,672 shares; shared voting/dispositive power covers 18,220,000 shares.
  • · Charles Kellogg disclaims beneficial ownership of shares held by Goose Creek Capital and its subsidiaries except for his pecuniary interest.
Sanara MedTech Inc. SC 13G/A negative materiality 6/10

31-07-2026

Tall Pines Capital, LLC and Stonebridge Wealth Management, LLC (both controlled by Christopher M. Plahm) filed an amended Schedule 13G reporting 0.0% beneficial ownership in Sanara MedTech Inc. as of July 30, 2026. The filing indicates the entities have disposed of all previously held common stock of the company, reducing their stake to zero.

  • · Filing type is an amendment (SC 13G/A) reflecting a change in ownership as of July 30, 2026.
  • · All reported holdings have been eliminated; no shares, voting power, or dispositive power remain.
  • · The filing is made under Rule 13d-1(c), indicating the filer is a passive investor.
  • · The filing certifies the securities were not held for the purpose of changing or influencing control of the issuer.
PARSONS CORP SC 13G/A neutral materiality 6/10

31-07-2026

Newport Trust Company, LLC disclosed a 46.15% beneficial ownership stake in Parsons Corp as of June 30, 2026, holding 49,370,624 shares of common stock. The filing is an amendment to Schedule 13G and indicates the shares were acquired and are held in the ordinary course of business, not for control purposes.

  • · The filing is an amendment to Schedule 13G (SC 13G/A), filed on July 31, 2026.
  • · Newport Trust Company, LLC is based in Washington, DC, with a business address at 1627 Eye Street, NW, Suite 950.
  • · The filing certifies that the securities were not acquired for the purpose of changing or influencing control of the issuer.
Pharvaris N.V. SC 13G/A neutral materiality 3/10

31-07-2026

LSP V Cooperatieve U.A. and its affiliate LSP V Management B.V. filed a Schedule 13G/A disclosing beneficial ownership of 3,424,609 ordinary shares of Pharvaris N.V., representing 4.9% of the outstanding shares as of June 30, 2026. The filing reflects a decrease from the prior 5%+ threshold, as the ownership percentage dropped below 5% following a share issuance by Pharvaris in May 2026. The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest.

  • · The filing is an amendment (SC 13G/A) to a previously filed Schedule 13G.
  • · The ownership percentage dropped to 4.9% from a prior level above 5% due to an increase in total outstanding shares following an underwritten offering that closed on May 11, 2026.
  • · LSP V Management B.V. is the sole director of LSP V Cooperatieve U.A., and its managing directors may be deemed to beneficially own the shares but disclaim such ownership.
Coeptis Therapeutics Holdings, Inc. SC 13G/A neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC filed a Schedule 13G/A disclosing beneficial ownership of 1,759,065 shares of Z Squared Inc. (formerly Coeptis Therapeutics Holdings, Inc.) as of June 30, 2026, representing 3.41% of the outstanding common stock. The filing is an amendment to a previous 13G and reflects Vanguard's passive investment in the company, with no intent to influence control.

  • · The filing is an amendment (Schedule 13G/A) filed on July 31, 2026, with an event date of June 30, 2026.
  • · Vanguard Capital Management LLC is based in Malvern, PA, and is an investment adviser (IA).
  • · The issuer, Z Squared Inc., is classified under SIC 6199 (Finance Services) and is incorporated in Delaware.
  • · Vanguard disclaims beneficial ownership of securities held by other subsidiaries or affiliates not listed in the filing.
  • · No single other person's interest in the reported securities exceeds 5%.
  • · The filing includes a certification that the securities were acquired in the ordinary course of business and not to change or influence control.
CASEYS GENERAL STORES INC SC 13G/A neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC filed a Schedule 13G/A with the SEC on July 31, 2026, disclosing beneficial ownership of 2,726,479 shares of Casey's General Stores Inc common stock, representing 7.36% of the outstanding shares. The filing is an amendment to a previous 13G and reflects Vanguard's passive investment in the company.

  • · Vanguard Capital Management LLC is a Pennsylvania limited liability company with its principal business address at 100 Vanguard Blvd, Malvern, PA 19355.
  • · The filing is made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
  • · Vanguard disclaims beneficial ownership of securities held by other subsidiaries or affiliates not included in this filing.
  • · No other person's interest in the reported securities exceeds 5%.
  • · The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
ASSOCIATED BANC-CORP SC 13G/A neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC filed a Schedule 13G/A with the SEC on July 31, 2026, reporting beneficial ownership of 7,927,724 shares of Associated Banc-Corp common stock as of June 30, 2026, representing 4.77% of the outstanding shares. The filing indicates a decrease in Vanguard's stake compared to the prior period, as the reported ownership is below the 5% threshold that typically triggers initial 13G filings.

  • · Vanguard reported sole voting power over 1,251,251 shares and sole dispositive power over 7,927,724 shares.
  • · The filing is made under Rule 13d-1(b), indicating the securities were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.
  • · No other person's interest in the reported securities exceeds 5%.
  • · The filing includes securities held by Vanguard funds and client accounts over which Vanguard Capital Management or its affiliates exercise dispositive and/or voting power.
Chatham Lodging Trust SC 13G/A neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC filed an amended Schedule 13G with the SEC on July 31, 2026, disclosing beneficial ownership of 2,296,248 common shares of Chatham Lodging Trust (CLDT-PA), representing 4.91% of the outstanding shares. The filing reflects a decrease from the prior 5%+ threshold, as Vanguard now holds below the 5% reporting threshold, indicating a reduction in its stake.

  • · Vanguard's filing is under Rule 13d-1(b), indicating passive investment intent.
  • · Vanguard holds sole dispositive power over all 2,296,248 shares but sole voting power over only 308,084 shares.
  • · The filing includes securities held by Vanguard funds and managed accounts, as well as certain affiliates.
  • · No single other person's interest in the reported securities exceeds 5%.
Compass, Inc. SC 13G neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC disclosed a 5.02% beneficial ownership stake in Compass, Inc. as of June 30, 2026, holding 37,563,557 shares of common stock. The filing is a routine Schedule 13G by a passive institutional investor, indicating no intent to influence control. No other material events or financial results were reported.

  • · The filing is made under Rule 13d-1(b) (passive investor exemption).
  • · Vanguard Capital Management LLC has sole dispositive power over all 37,563,557 shares but no voting power (0 shares).
  • · The filing includes securities held by Vanguard funds and managed accounts, with no single beneficial owner exceeding 5% of the reported securities.
  • · The filing date is July 31, 2026, with the ownership snapshot as of June 30, 2026.
ANAVEX LIFE SCIENCES CORP. SC 13G neutral materiality 5/10

31-07-2026

Vanguard Capital Management LLC disclosed a 5.03% beneficial ownership stake in Anavex Life Sciences Corp. as of June 30, 2026, holding 4,663,459 shares of common stock. The filing was made under Rule 13d-1(b) and certifies that the securities were acquired in the ordinary course of business, not to influence control of the issuer.

  • · Vanguard has sole voting power over 608,870 shares and sole dispositive power over all 4,663,459 shares.
  • · The filing is a Schedule 13G (passive investment), not a 13D (activist intent).
  • · No single other person's interest in the reported securities exceeds 5%.
  • · The filing date is July 31, 2026, with the beneficial ownership date as of June 30, 2026.
LESAKA TECHNOLOGIES INC SC 13G/A neutral materiality 3/10

31-07-2026

Apis Growth 13 Ltd and its directors, Mr. Sattish Lalljee and Mr. Xie Fei Pang Wong Lin, filed an amended Schedule 13G disclosing beneficial ownership of 1,719,368 shares of Lesaka Technologies Inc. common stock, representing 2.1% of the 85,736,223 shares outstanding as of May 4, 2026. The filing indicates no change in the number of shares held compared to the prior filing, and the filers certify they do not hold the securities for control purposes.

  • · The filing is an amendment (Schedule 13G/A) filed on July 31, 2026.
  • · The filers are based in Mauritius and South Africa.
  • · The securities are held for investment purposes, not to influence control of the issuer.
INNODATA INC SC 13G neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC disclosed a 5.0% beneficial ownership stake in Innodata Inc as of June 30, 2026, holding 1,633,779 common shares. The filing is a routine Schedule 13G by a passive institutional investor, indicating no intent to influence control.

  • · Vanguard Capital Management LLC filed under Rule 13d-1(b), confirming passive investment intent.
  • · The filing includes securities held by Vanguard funds and managed accounts, with no single beneficial owner exceeding 5%.
  • · Vanguard disclaims beneficial ownership of securities held by other subsidiaries or affiliates not listed.
EZCORP INC SC 13G neutral materiality 5/10

31-07-2026

Vanguard Capital Management LLC disclosed a 5.02% beneficial ownership stake in EZCORP Inc as of June 30, 2026, holding 2,943,659 shares of common stock. The filing is a Schedule 13G submitted under Rule 13d-1(b), indicating passive investment intent. Vanguard also reported sole dispositive power over 2,943,659 shares and sole voting power over 439,753 shares.

  • · Filing date: July 31, 2026
  • · As of date: June 30, 2026
  • · Vanguard has sole dispositive power over all 2,943,659 shares
  • · Vanguard has sole voting power over only 439,753 shares
  • · No other person's interest in the reported securities exceeds 5%
  • · The filing certifies the securities were acquired and are held in the ordinary course of business, not to change or influence control of the issuer
CONAGRA BRANDS INC. SC 13G/A neutral materiality 5/10

31-07-2026

Vanguard Capital Management LLC disclosed a 5.28% beneficial ownership stake in Conagra Brands Inc. as of June 30, 2026, holding 25,308,895 shares of common stock. The filing, an amendment to Schedule 13G, indicates the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

  • · Vanguard Capital Management holds sole voting power over 3,744,650 shares and sole dispositive power over all 25,308,895 shares.
  • · The filing is made under Rule 13d-1(b) (passive investment exemption).
  • · No other person's interest in the reported securities exceeds 5%.
  • · The filing includes securities held by Vanguard funds and managed accounts, as well as certain affiliates.
GCM Grosvenor Inc. SC 13G/A neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC filed a Schedule 13G/A with the SEC on July 31, 2026, disclosing beneficial ownership of 2,982,847 shares of GCM Grosvenor Inc. common stock, representing 4.93% of the outstanding shares. The filing reflects a passive investment held in the ordinary course of business, with no intention to change or influence control of the issuer.

  • · Vanguard Capital Management LLC is based in Malvern, PA.
  • · The filing is made under Rule 13d-1(b) (passive investment).
  • · Vanguard disclaims beneficial ownership of securities held by other subsidiaries or affiliates not listed.
  • · No other person's interest in the reported securities exceeds 5%.
  • · The filing includes securities held by Vanguard funds and sleeves over which Vanguard Capital Management exercises dispositive power.
IDEAYA Biosciences, Inc. SC 13G neutral materiality 5/10

31-07-2026

Vanguard Capital Management LLC disclosed a 5.08% beneficial ownership stake in IDEAYA Biosciences, Inc. as of June 30, 2026, holding 4,834,771 shares of common stock. The filing is a routine Schedule 13G by a passive institutional investor, indicating no intent to influence control of the company.

  • · Vanguard Capital Management has sole dispositive power over all 4,834,771 shares but sole voting power over only 702,125 shares.
  • · The filing is made under Rule 13d-1(b), confirming passive investor status.
  • · No single other person's interest in the reported securities exceeds 5%.
Eledon Pharmaceuticals, Inc. SC 13G neutral materiality 5/10

31-07-2026

Vanguard Capital Management LLC disclosed a 5.05% beneficial ownership stake in Eledon Pharmaceuticals, Inc. as of June 30, 2026, holding 3,898,446 shares of common stock. The filing, made under Rule 13d-1(b), indicates the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the company.

  • · Vanguard Capital Management has sole dispositive power over 3,898,446 shares and shared voting power over 481,223 shares.
  • · The filing includes shares held by Vanguard funds and managed accounts, as well as certain affiliates.
  • · No other person's interest in the reported securities exceeds 5%.
  • · The filing was made under Rule 13d-1(b), indicating passive investment intent.
CHART INDUSTRIES INC SC 13G neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC disclosed a 5.15% beneficial ownership stake in Chart Industries Inc as of June 30, 2026, holding 2,466,609 shares of common stock. The filing is a routine Schedule 13G filed under Rule 13d-1(b), indicating passive investment intent with no aim to influence control of the company.

  • · The filing is made under Rule 13d-1(b), confirming passive investment intent.
  • · Vanguard Capital Management LLC has sole dispositive power over 2,466,609 shares and sole voting power over 347,556 shares.
  • · No other person's interest in the reported securities exceeds 5%.
  • · The filing includes securities held by Vanguard funds and managed accounts, as well as certain affiliates.
Citizens Community Bancorp Inc. SC 13G/A neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC filed a Schedule 13G/A with the SEC on July 31, 2026, disclosing beneficial ownership of 477,358 shares of Citizens Community Bancorp Inc. common stock, representing 4.94% of the outstanding shares as of June 30, 2026. The filing reflects a passive investment held in the ordinary course of business, with no intent to influence control of the issuer.

  • · The filing is an amendment (Schedule 13G/A) to a prior Schedule 13G.
  • · Vanguard Capital Management LLC has sole voting power over 63,982 shares and sole dispositive power over all 477,358 shares.
  • · The securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
  • · No other person's interest in the reported securities exceeds 5%.
COMTECH TELECOMMUNICATIONS CORP /DE/ SC 13G neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC disclosed a 5.01% beneficial ownership stake in Comtech Telecommunications Corp as of June 30, 2026, holding 1,503,083 common shares. The filing is a routine Schedule 13G by a passive institutional investor, indicating no intent to influence control of the company.

  • · Vanguard Capital Management LLC is based in Malvern, PA.
  • · The filing is made under Rule 13d-1(b), confirming passive investment intent.
  • · Vanguard Capital Management has sole dispositive power over 1,503,083 shares and sole voting power over 196,179 shares.
  • · No single other person's interest in the reported securities exceeds 5%.
COLONY BANKCORP INC SC 13G/A neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC filed a Schedule 13G/A with the SEC, disclosing beneficial ownership of 1,042,729 shares of Colony Bankcorp Inc (CBAN) common stock as of June 30, 2026. This represents a 4.92% stake in the company. The filing is an amendment to a previous Schedule 13G and reflects Vanguard's passive investment in the bank.

  • · Vanguard disclaims beneficial ownership of securities held by other subsidiaries or affiliates not listed in the filing.
  • · The filing certifies that the securities were acquired and are held in the ordinary course of business, not for changing or influencing control of the issuer.
  • · No single person other than Vanguard has an interest of more than 5% in the reported securities.
BlueLinx Holdings Inc. SC 13G/A neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC filed a Schedule 13G/A with the SEC on July 31, 2026, disclosing beneficial ownership of 385,220 shares of BlueLinx Holdings Inc. common stock, representing 4.94% of the outstanding shares as of June 30, 2026. The filing indicates a passive investment intent, with Vanguard holding the shares in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

  • · The filing is an amendment (Schedule 13G/A) to a previous Schedule 13G.
  • · Vanguard Capital Management LLC has sole voting power over 52,135 shares and sole dispositive power over 385,220 shares.
  • · The filing includes securities held by Vanguard funds and managed accounts, as well as certain affiliates, but excludes securities held by other subsidiaries or affiliates whose ownership is disaggregated.
  • · No other person's interest in the reported securities exceeds 5%.
  • · The filing is made under Rule 13d-1(b), indicating passive investment intent.
ARBOR REALTY TRUST INC SC 13G neutral materiality 30/10

31-07-2026

Vanguard Capital Management LLC disclosed a 5.08% beneficial ownership stake in Arbor Realty Trust Inc (ABR) as of June 30, 2026, holding 9,777,693 shares of common stock. The filing is a Schedule 13G, indicating passive investment intent, and includes shares held by Vanguard affiliates and managed accounts. No change in ownership was reported compared to the prior period, and the stake remains just above the 5% threshold.

  • · The filing is made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934, indicating passive investment.
  • · Vanguard Capital Management LLC has sole dispositive power over 9,777,693 shares and sole voting power over 1,467,640 shares.
  • · The stake is held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
  • · No other person's interest in the reported securities exceeds 5%.
Brookdale Senior Living Inc. SC 13G neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC filed a Schedule 13G with the SEC on July 31, 2026, disclosing beneficial ownership of 11,961,822 shares of Brookdale Senior Living Inc. common stock, representing 5.0% of the outstanding shares. The filing indicates Vanguard holds the shares in the ordinary course of business for investment purposes, with no intent to change or influence control of the company.

  • · The filing was made under Rule 13d-1(b), indicating passive investment intent.
  • · Vanguard Capital Management LLC has sole voting power over 1,772,020 shares and sole dispositive power over all 11,961,822 shares.
  • · No single person other than Vanguard has an interest in more than 5% of the reported securities.
  • · The filing includes securities held by Vanguard funds and managed accounts, as well as certain affiliates.
CANADIAN IMPERIAL BANK OF COMMERCE /CAN/ SC 13G neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC disclosed a 5.01% beneficial ownership stake in Canadian Imperial Bank of Commerce (CIBC) as of June 30, 2026, holding 45,902,841 common shares. The filing is a routine Schedule 13G filing by a passive institutional investor, indicating no intent to influence control of the issuer.

  • · The filing is made under Rule 13d-1(b), indicating passive investment intent.
  • · Vanguard Capital Management has sole dispositive power over 45,902,841 shares and sole voting power over 17,759,602 shares.
  • · No other person's interest in the reported securities exceeds 5%.
  • · The filing includes securities held by Vanguard funds and managed accounts, as well as certain affiliates.
COHU INC SC 13G neutral materiality 5/10

31-07-2026

Vanguard Capital Management LLC filed a Schedule 13G with the SEC on July 31, 2026, disclosing beneficial ownership of 2,365,526 shares of Cohu Inc (COHU) common stock as of June 30, 2026. This represents a 5.01% stake in the company, making Vanguard a significant shareholder. The filing is a routine disclosure under Rule 13d-1(b) and indicates the shares were acquired and are held in the ordinary course of business, not for changing or influencing control of the issuer.

  • · Vanguard Capital Management LLC holds sole voting power over 358,189 shares and sole dispositive power over all 2,365,526 shares.
  • · The filing includes securities held by Vanguard funds and managed accounts, as well as affiliates such as Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC, and Vanguard Investments Australia Ltd.
  • · No other person's interest in the reported securities exceeds 5%.
  • · The filing is made under Rule 13d-1(b), indicating passive investment intent.
AVANOS MEDICAL, INC. SC 13G neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC filed a Schedule 13G with the SEC on July 31, 2026, disclosing beneficial ownership of 2,344,195 shares of Avanos Medical, Inc. common stock as of June 30, 2026. This represents approximately 5.0% of the outstanding shares, making Vanguard a major shareholder. The filing is a routine passive ownership disclosure under Rule 13d-1(b) and does not indicate any intent to influence control.

  • · The filing is made under Rule 13d-1(b), indicating passive investment intent.
  • · Vanguard Capital Management LLC has sole voting power over 350,401 shares and sole dispositive power over all 2,344,195 shares.
  • · The filing includes securities held by Vanguard funds and managed accounts where Vanguard Capital Management exercises dispositive power.
  • · No other person's interest in the reported securities exceeds 5%.
BAR HARBOR BANKSHARES SC 13G/A neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC filed a Schedule 13G/A with the SEC on July 31, 2026, disclosing beneficial ownership of 830,512 shares of Bar Harbor Bankshares (BHB) common stock, representing 4.96% of the outstanding shares. The filing indicates a passive investment intent, with Vanguard holding the shares in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

  • · The filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
  • · Vanguard Capital Management LLC has sole dispositive power over 830,512 shares and sole voting power over 109,538 shares.
  • · The filing includes securities held by Vanguard funds and managed accounts, as well as certain affiliates.
  • · No other person's interest in the reported securities exceeds 5%.
  • · The filing is made under Rule 13d-1(b), indicating passive investment intent.
CEVA INC SC 13G neutral materiality 4/10

31-07-2026

Vanguard Capital Management LLC reported beneficial ownership of 1,406,251 shares of CEVA Inc common stock, representing 5.04% of the outstanding shares as of 06/30/2026, via a Schedule 13G filed 07/31/2026. The filing notes holdings are held in the ordinary course of business and not for the purpose of influencing control; no other person has an interest above 5%.

  • · Filing type: Schedule 13G filed on 07/31/2026 covering holdings as of 06/30/2026.
  • · Vanguard Capital Management's business address: 100 Vanguard Blvd, Malvern, PA 19355; CEVA Inc business address: 15245 Shady Grove Road, Suite 400, Rockville, MD 20850.
  • · The filing states the reported securities include those held by Vanguard funds and managed accounts over which Vanguard Capital Management LLC or specified affiliates exercise dispositive power, but excludes securities of other Vanguard subsidiaries/affiliates whose holdings are disaggregated.
  • · The filer certifies the securities were acquired and are held in the ordinary course of business and not to influence control of the issuer.
Bancorp, Inc. SC 13G neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC filed a Schedule 13G with the SEC on July 31, 2026, disclosing beneficial ownership of 2,082,956 shares of Bancorp, Inc. (TBBK) common stock as of June 30, 2026. This represents approximately 5.0% of the outstanding shares, based on the 41.9 million shares outstanding as of the most recent filing. The filing is a routine disclosure of passive investment and does not indicate any change in control intent.

  • · The filing is made under Rule 13d-1(b), indicating the securities were acquired in the ordinary course of business and not with the purpose of changing or influencing control.
  • · Vanguard Capital Management LLC has sole voting power over 311,534 shares and sole dispositive power over all 2,082,956 shares.
  • · No other person's interest in the reported securities exceeds 5%.
  • · The filing includes securities held by Vanguard funds and managed accounts, as well as certain affiliates, but excludes other subsidiaries whose ownership is disaggregated per SEC Release No. 34-39538.
BASSETT FURNITURE INDUSTRIES INC SC 13G/A neutral materiality 3/10

31-07-2026

Vanguard Capital Management LLC filed a Schedule 13G/A with the SEC on July 31, 2026, disclosing beneficial ownership of 414,801 shares of Bassett Furniture Industries Inc common stock as of June 30, 2026. This represents a 4.79% stake in the company, which is below the 5% threshold that typically triggers heightened regulatory scrutiny. The filing indicates Vanguard's holdings are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

  • · Vanguard holds sole voting power over 55,698 shares and sole dispositive power over 414,801 shares.
  • · The filing is an amendment (Schedule 13G/A) to a prior beneficial ownership report.
  • · Vanguard's stake is below the 5% threshold, indicating no control intent.
  • · The filing includes securities held by Vanguard funds and managed accounts, as well as certain affiliates.
CENTRUS ENERGY CORP SC 13G neutral materiality 5/10

31-07-2026

On July 31, 2026, Vanguard Capital Management LLC filed a Schedule 13G with the SEC, disclosing beneficial ownership of 951,867 shares of Centrus Energy Corp (LEU) common stock, representing 5.02% of the outstanding shares. The filing indicates that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer. No prior-period comparison is available in this initial filing.

  • · Vanguard Capital Management LLC holds sole dispositive power over all 951,867 shares.
  • · The filing is made pursuant to Rule 13d-1(b) and includes shares held by Vanguard funds and managed accounts over which Vanguard Capital Management exercises dispositive power.
  • · Affiliates included in the filing are Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC, and Vanguard Investments Australia Ltd.
  • · No other person's interest in the reported securities exceeds 5%.
BRADY CORP SC 13G neutral materiality 5/10

31-07-2026

Vanguard Capital Management LLC disclosed a 5.01% beneficial ownership stake in Brady Corp (BRC) as of June 30, 2026, holding 2,186,783 shares of common stock. The Schedule 13G filing indicates a passive investment intent with no aim to change or influence control of the company. The filing is in the ordinary course of business.

  • · Vanguard's beneficial ownership was 5.01% of Brady Corp's common stock as of June 30, 2026.
  • · Vanguard has sole dispositive power over all 2,186,783 shares but sole voting power over only 329,490 shares.
  • · The filing is under Rule 13d-1(b), confirming passive investment intent.

Get daily alerts with 11 investment signals, 8 risk alerts, 9 opportunities and full AI analysis of all 50 filings

Start free trial Browse all digests

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Activist Hedge Fund Institutional SEC 13D 13G

July 23, 2026

US Activist Hedge Fund Institutional SEC 13D 13G — July 23, 2026

July 21, 2026

US Activist Hedge Fund Institutional SEC 13D 13G — July 21, 2026

July 20, 2026

US Activist Hedge Fund Institutional SEC 13D 13G — July 20, 2026

July 17, 2026

US Activist Hedge Fund Institutional SEC 13D 13G — July 17, 2026

🇺🇸 More from United States

View all →

July 24, 2026

US Pre-Market SEC Filings Roundup — July 24, 2026

US Pre-Market SEC Filings Roundup

July 24, 2026

USA Corporate Events Calendar — July 24, 2026

USA Corporate Events Calendar

July 24, 2026

USA Earnings Calls Schedule — July 24, 2026

USA Earnings Calls Schedule

July 24, 2026

S&P 500 Technology Sector SEC Filings — July 24, 2026

S&P 500 Technology Sector SEC Filings
← All United States digests